18.03

1.21% -0.2052

Schrodinger Inc (SDGR)

Overview News Price History Option Chain Financials Why SDGR Down? Discussions Forecast

Schrodinger Inc stock is traded at $18.03, with a volume of 561.09K. It is down -1.21% in the last 24 hours and up +2.91% over the past month. Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Previous Close:

$18.24

Open:

$18.12

24h Volume:

561.09K

Relative Volume:

0.97

Market Cap:

$1.32B

Revenue:

$188.48M

Net Income/Loss:

$-143.14M

P/E Ratio:

32.20

EPS:

0.56

Net Cash Flow:

$-158.83M

1W Performance:

-3.84%

1M Performance:

+2.91%

6M Performance:

-23.90%

1Y Performance:

-36.41%

1-Day Range:

$17.73

$18.26

1-Week Range:

$17.28

$18.92

52-Week Range:

$16.67

$38.00

Schrodinger Inc Stock (SDGR) Company Profile

Name

Schrodinger Inc

Sector

Healthcare (1181)

Industry

Health Information Services (61)

Phone

503-299-1150

Address

1540 BROADWAY, NEW YORK, NY

Employee

787

Twitter

@schrodinger

Next Earnings Date

2024-11-12

Latest SEC Filings

SDGR's Discussions on Twitter

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight
May-05-23	Resumed	Piper Sandler	Overweight
Dec-19-22	Initiated	Goldman	Neutral
Mar-01-22	Initiated	Citigroup	Buy
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-19-21	Initiated	Piper Sandler	Overweight
Nov-11-21	Downgrade	BofA Securities	Buy → Neutral
Oct-13-21	Initiated	Berenberg	Buy
Sep-01-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-25-21	Initiated	Craig Hallum	Buy
Nov-23-20	Upgrade	BofA Securities	Neutral → Buy
Oct-12-20	Upgrade	Jefferies	Hold → Buy
Mar-02-20	Initiated	BMO Capital Markets	Outperform
Mar-02-20	Initiated	Jefferies	Hold
Mar-02-20	Initiated	Morgan Stanley	Equal-Weight

View All

Schrodinger Inc Stock (SDGR) Latest News

04:28 AM

Schrödinger to Present at Jefferies London Healthcare Conference - BioSpace

04:28 AM

Nov 04, 2024

(SDGR) Long Term Investment Analysis - Stock Traders Daily

Nov 04, 2024

Nov 03, 2024

How to Profit From an AI-Driven Biotech That Has Lost Half Its Value in 2024 - RealMoney

Nov 03, 2024

Nov 01, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Shares Acquired by Stephens Investment Management Group LLC - MarketBeat

Nov 01, 2024

Oct 31, 2024

Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 - Yahoo Finance

Oct 31, 2024

Oct 28, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 28, 2024

Oct 24, 2024

Trading (SDGR) With Integrated Risk Controls - Stock Traders Daily

Oct 24, 2024

Oct 23, 2024

Stanley Laman Group Ltd. Sells 33,556 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat

Oct 23, 2024

Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium - Business Wire

Oct 23, 2024

Oct 22, 2024

Schrödinger’s Akinsanya On Low-Risk Pipeline Growth And Platform Evolution - Citeline

Oct 21, 2024

Oct 18, 2024

Schrödinger, Inc. Continues To Be A Complicated Story (NASDAQ:SDGR) - Seeking Alpha

Oct 18, 2024

Oct 17, 2024

Schrödinger (NASDAQ:SDGR) Price Target Cut to $25.00 - MarketBeat

Oct 17, 2024

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Oct 17, 2024

Schrodinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty (NASDAQ:SDGR) - Seeking Alpha

Oct 17, 2024

Schrodinger's chief medical officer sells $27,225 in stock - Investing.com India

Oct 17, 2024

Schrodinger's chief medical officer sells $27,225 in stock By Investing.com - Investing.com Australia

Oct 17, 2024

Oct 16, 2024

Schrödinger, Inc. (NASDAQ:SDGR) Insider Sells $27,221.18 in Stock - MarketBeat

Oct 16, 2024

Oct 13, 2024

How to Take Advantage of moves in (SDGR) - Stock Traders Daily

Oct 13, 2024

Oct 11, 2024